Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18720311 | APPARATUS AND METHOD FOR DETERMINING THE CONDITION OF STRUCTURES IN THE BODY | June 2024 | February 2026 | Abandon | 20 | 1 | 0 | No | No |
| 18598481 | DEVICE AND METHODS TO TREAT INFECTIONS, INFLAMMATIONS AND TUMORS IN ORGANS AND TISSUES AND TO EXTEND THE UTILITY OF ANTIBIOTICS | March 2024 | October 2025 | Abandon | 19 | 2 | 0 | No | No |
| 18215370 | TRANSPERINEAL STEPPER INCLUDING ROTATABLE TRANSDUCER PROBE AND SHAFT WITH INTERNAL CABLE | June 2023 | June 2025 | Abandon | 24 | 2 | 0 | No | No |
| 18123003 | METHODS TO TREAT CANCER, INFLAMMATIONS AND TUMORS | March 2023 | October 2025 | Abandon | 31 | 2 | 0 | No | No |
| 18004138 | ULTRASOUND TRANSDUCER PROBE WITH MULTI-ROW ARRAY ACOUSTIC STACKS AND ULTRASOUND IMAGING SYSTEM | January 2023 | March 2026 | Abandon | 38 | 2 | 0 | No | No |
| 17963145 | SYSTEMS AND METHODS OF ESTABLISHING A COMMUNICATION SESSION FOR LIVE REVIEW OF ULTRASOUND SCANNING | October 2022 | January 2025 | Abandon | 27 | 3 | 0 | Yes | No |
| 17937157 | DRUG-COATED BALLOON DEVICE, SYSTEM, AND PROCEDURE | September 2022 | January 2026 | Abandon | 40 | 0 | 1 | No | No |
| 17660709 | INTERVENTIONAL LOCALIZATION GUIDE AND METHOD FOR MRI GUIDED PELVIC INTERVENTIONS | April 2022 | December 2024 | Abandon | 31 | 0 | 1 | No | No |
| 17633400 | DEVICE FOR HOLDING A MEDICAL INSTRUMENT AND APPARATUS COMPRISING SUCH A DEVICE | February 2022 | September 2025 | Abandon | 43 | 3 | 1 | No | No |
| 17532421 | ULTRASOUND TRANSPERINEAL PUNCTURE DEVICE GUIDE WITH A PIVOTABLE NEEDLE HOLDER | November 2021 | April 2024 | Allow | 29 | 3 | 0 | Yes | No |
| 17525193 | PUNCTURE INFORMATION PROCESSING DEVICE, ULTRASONIC LAPAROSCOPIC PUNCTURING SYSTEM, PUNCTURE INFORMATION PROCESSING METHOD, AND STORAGE MEDIUM | November 2021 | October 2024 | Abandon | 36 | 3 | 0 | Yes | No |
| 17521135 | ULTRASONIC DETECTION OF CATHETER LOCATION AND VEIN DEFORMATION DETECTION BY ABLATION CATHETER | November 2021 | August 2024 | Abandon | 33 | 1 | 1 | No | No |
| 17484809 | ULTRASOUND TRANSDUCER | September 2021 | November 2025 | Allow | 49 | 4 | 1 | Yes | Yes |
| 17431054 | ARTICLE OF CLOTHING AND METHOD FOR CONTROLLING CELLS USING SUCH AN ARTICLE OF CLOTHING | August 2021 | August 2025 | Abandon | 48 | 2 | 1 | No | No |
| 17382173 | ULTRASOUND IMAGING SYSTEM USING COHERENCE ESTIMATION OF A BEAMFORMED SIGNAL | July 2021 | October 2025 | Abandon | 51 | 4 | 1 | No | No |
| 17301413 | METHOD AND APPARATUS FOR COMPOSITION OF ULTRASOUND IMAGES WITH INTEGRATION OF "THICK-SLICE" 3-DIMENSIONAL ULTRASOUND IMAGING ZONE(S) AND 2-DIMENSIONAL ULTRASOUND ZONE(S) UTILIZING A MULTI-ZONE, MULTI-FREQUENCY ULTRASOUND IMAGE RECONSTRUCTION SCHEME WITH SUB-ZONE BLENDING | April 2021 | March 2024 | Allow | 35 | 2 | 0 | No | No |
| 17212067 | BIOLOGICAL INFORMATION MONITORING APPARATUS AND MAGNETIC RESONANCE APPARATUS | March 2021 | April 2025 | Allow | 48 | 3 | 1 | Yes | No |
| 17187281 | METHOD AND SYSTEM OF QUANTIFYING LESION EVOLUTION | February 2021 | August 2025 | Abandon | 54 | 5 | 0 | No | No |
| 17185182 | Scan-less Optically Computed Optical Coherence Tomography Using a Spatial Light Modulator | February 2021 | March 2024 | Allow | 37 | 2 | 1 | Yes | No |
| 17271019 | IMAGING PLANE CONTROL AND DISPLAY FOR INTRALUMINAL ULTRASOUND, AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS | February 2021 | February 2026 | Abandon | 60 | 6 | 0 | No | Yes |
| 17171348 | SYSTEMS AND METHODS FOR 3D ULTRASOUND IMAGING OF EXTENDED TARGETS USING INTERCHANGEABLE TRACK STANDS | February 2021 | December 2023 | Allow | 34 | 3 | 0 | No | No |
| 17168213 | INTUITIVE DISPLAY FOR ROTATOR CUFF TEAR DIAGNOSTICS | February 2021 | July 2024 | Allow | 41 | 4 | 0 | Yes | Yes |
| 17157838 | SIMULTANEOUS ULTRASONIC IMAGING AND LOW INTENSITY FOCUSED ULTRASOUND THERAPY | January 2021 | November 2023 | Allow | 34 | 2 | 1 | Yes | No |
| 17125879 | Measurement of Distal End Dimension of Catheters Using Magnetic Fields | December 2020 | September 2024 | Allow | 45 | 4 | 0 | Yes | No |
| 17116918 | DEVICES, SYSTEMS, AND METHODS FOR TRANS-VAGINAL, ULTRASOUND-GUIDED HYSTEROSCOPIC SURGICAL PROCEDURES | December 2020 | February 2025 | Allow | 51 | 5 | 0 | No | No |
| 17247323 | NON-INVASIVE BLOOD PRESSURE ESTIMATION AND BLOOD VESSEL MONITORING BASED ON PHOTOACOUSTIC PLETHYSMOGRAPHY | December 2020 | October 2025 | Abandon | 58 | 6 | 0 | Yes | Yes |
| 17109886 | PERCUTANEOUS ACCESS NEEDLE GUIDANCE SYSTEMS AND METHODS USING AN ACCESS NEEDLE AND GUIDANCE PAD | December 2020 | August 2024 | Allow | 45 | 3 | 1 | Yes | No |
| 17057772 | APPARATUS AND METHOD FOR ESTIMATING A LEVEL OF THERMAL ABLATION | November 2020 | August 2024 | Abandon | 44 | 4 | 0 | No | No |
| 17097166 | DEVICE AND METHODS TO TREAT INFECTIONS, INFLAMMATIONS AND TUMORS IN ORGANS AND TISSUES AND TO EXTEND THE UTILITY OF ANTIBIOTICS | November 2020 | June 2024 | Abandon | 43 | 3 | 1 | Yes | No |
| 17065230 | SYSTEMS AND METHODS FOR SIMULTANEOUS MONITORING OF HUMAN NERVE DISPLACEMENT | October 2020 | November 2024 | Abandon | 49 | 4 | 0 | No | No |
| 17041692 | ULTRASOUND BASED THREE-DIMENSIONAL LESION VERIFICATION WITHIN A VASCULATURE | September 2020 | November 2025 | Allow | 60 | 9 | 0 | Yes | No |
| 16932182 | SYSTEMS AND METHODS FOR PATIENT POSITIONING FOR IMAGING ACQUISITION | July 2020 | October 2024 | Abandon | 50 | 6 | 0 | Yes | No |
| 16959914 | MULTI-FREQUENCY ULTRASOUND TRANSDUCERS | July 2020 | June 2024 | Abandon | 47 | 4 | 0 | Yes | No |
| 16768794 | SENSOR INSERTION DEVICE | June 2020 | March 2024 | Abandon | 45 | 5 | 0 | Yes | No |
| 16879979 | DEVICE AND METHODS TO DESTROY BACTERIA, MOLDS, FUNGI AND VIRUSES AND FOR REDUCING INFLAMMATION AND MARKERS IN ORGANS AND TISSUE AND TO EXTEND THE UTILITY OF ANTIBIOTICS | May 2020 | January 2024 | Abandon | 43 | 2 | 1 | Yes | No |
| 16806291 | REGISTRATION WITH TRAJECTORY INFORMATION WITH SHAPE SENSING | March 2020 | March 2024 | Abandon | 49 | 3 | 1 | No | No |
| 16801122 | PREPARING AND MAPPING A TUBE-SHAPED STRUCTURE | February 2020 | September 2025 | Abandon | 60 | 6 | 1 | Yes | No |
| 16632128 | FLEXIBLE ELONGATE DEVICE SYSTEMS AND METHODS | January 2020 | November 2025 | Abandon | 60 | 6 | 0 | Yes | No |
| 16740640 | HEARTBEAT INDEX DETERMINATION APPARATUS AND METHOD | January 2020 | August 2025 | Abandon | 60 | 5 | 1 | No | No |
| 16623964 | CONTROL METHOD FOR THE TREATMENT OF BRAIN TISSUE USING AN ULTRASONIC PROBE AND AN IMPLANTED ACOUSTIC WINDOW ON THE CRANIUM | December 2019 | August 2023 | Allow | 44 | 3 | 0 | Yes | No |
| 16680244 | DYNAMIC VITAL-SIGN DETECTION SYSTEM AND METHOD | November 2019 | August 2024 | Abandon | 57 | 5 | 0 | No | No |
| 16676647 | BLOOD PRESSURE MEASURING APPARATUS AND BLOOD PRESSURE MEASURING METHOD | November 2019 | May 2024 | Abandon | 54 | 4 | 1 | Yes | No |
| 16655736 | SMART DEVICE AND SYSTEM FOR TREATMENT OF GASTRIC REFLUX | October 2019 | May 2024 | Abandon | 55 | 2 | 1 | Yes | No |
| 16528406 | OPTICAL FLOW ANALYSIS METHOD AND DETECTION DEVICE | July 2019 | March 2025 | Abandon | 60 | 6 | 0 | Yes | No |
| 16347620 | CORRECTION METHOD FOR MAGNETIC RESONANCE T1-MAPPING OF VISCERAL ORGANS IN THE PRESENCE OF ELEVATED IRON AND ELEVATED FAT LEVELS, AND IN THE PRESENCE OF OFF-RESONANCE FREQUENCIES | May 2019 | January 2025 | Abandon | 60 | 5 | 0 | Yes | No |
| 16341240 | MODULAR ULTRASOUND APPARATUS AND METHODS | April 2019 | December 2024 | Allow | 60 | 5 | 1 | Yes | No |
| 16375654 | SURGICAL NAVIGATION METHOD AND SYSTEM USING AUGMENTED REALITY | April 2019 | March 2025 | Abandon | 60 | 4 | 0 | Yes | No |
| 16242769 | LOCATING BAR AND PATIENT SUPPORT SYSTEM | January 2019 | November 2025 | Abandon | 60 | 8 | 0 | Yes | No |
| 16146229 | ULTRASONIC OSCILLATOR UNIT | September 2018 | August 2025 | Abandon | 60 | 7 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BASET, NESHAT.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner BASET, NESHAT works in Art Unit 3798 and has examined 40 patent applications in our dataset. With an allowance rate of 35.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 49 months.
Examiner BASET, NESHAT's allowance rate of 35.0% places them in the 6% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by BASET, NESHAT receive 4.20 office actions before reaching final disposition. This places the examiner in the 98% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by BASET, NESHAT is 49 months. This places the examiner in the 7% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +17.7% benefit to allowance rate for applications examined by BASET, NESHAT. This interview benefit is in the 59% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 12.3% of applications are subsequently allowed. This success rate is in the 7% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 2.9% of cases where such amendments are filed. This entry rate is in the 4% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 150.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 90% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 100% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 200.0% are granted (fully or in part). This grant rate is in the 100% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 49% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.